Madan Ajay 5
5 · Crinetics Pharmaceuticals, Inc. · Filed Feb 5, 2021
Insider Transaction Report
Form 5
Madan Ajay
Chief Development Officer
Transactions
- Other
Common Stock
2020-05-20$14.45/sh+1,470$21,242→ 77,516 total
Footnotes (1)
- [F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),